|
Re: New Apabetalone Fabry Disease Publication
|
5
|
Resverlogix Corp.
|
Apr 27, 2022 06:45PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
8
|
Resverlogix Corp.
|
Apr 26, 2022 01:27PM
|
|
Re: New blog entry: Disrupting Treatment of Cardiovascular Disease with Epigenetics
|
3
|
Resverlogix Corp.
|
Aug 27, 2015 10:47AM
|
|
Re: NEW BLOG POST
|
2
|
Resverlogix Corp.
|
Jun 17, 2015 05:27PM
|
|
Re: NEW BLOG POST
|
2
|
Resverlogix Corp.
|
Jun 18, 2015 08:27AM
|
|
Re: NEW BLOG POST
|
2
|
Resverlogix Corp.
|
Jun 18, 2015 09:08AM
|
|
Re: NEW COMMENT BY AUTHOR RE SA RVX ARTICLE
|
3
|
Resverlogix Corp.
|
Aug 08, 2015 12:25PM
|
|
Re: New exempt distribution
|
3
|
Resverlogix Corp.
|
May 06, 2021 11:39AM
|
|
Re: New Interim Financials and MD&A docs on SEDAR
|
2
|
Resverlogix Corp.
|
Dec 17, 2015 09:27AM
|
|
Re: New Interim Financials and MD&A docs on SEDAR
|
|
Resverlogix Corp.
|
Dec 17, 2015 06:19PM
|
|
Re: New Interim Financials and MD&A docs on SEDAR
|
1
|
Resverlogix Corp.
|
Dec 17, 2015 06:24PM
|
|
Re: New MD&A posted
|
4
|
Resverlogix Corp.
|
Dec 17, 2019 10:41PM
|
|
Re: NEW NR
|
3
|
Resverlogix Corp.
|
Aug 04, 2015 10:46AM
|
|
Re: New patent (January)
|
3
|
Resverlogix Corp.
|
Feb 24, 2016 06:55PM
|
|
Re: New pill from Pfizer....
|
8
|
Resverlogix Corp.
|
Mar 24, 2021 11:02AM
|
|
Re: New PP on Aug 13
|
2
|
Zenith Epigenetics
|
Aug 21, 2019 07:40AM
|
|
Re: New Publication
|
4
|
Resverlogix Corp.
|
Feb 28, 2023 06:17PM
|
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
6
|
Resverlogix Corp.
|
May 12, 2016 07:06PM
|
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
4
|
Resverlogix Corp.
|
May 15, 2016 05:04PM
|
|
Re: New Share Price Contest
|
3
|
Resverlogix Corp.
|
Oct 11, 2019 11:28AM
|
